Abstract Introduction: Splanchnic and renal artery aneurysms (SRAAs) are uncommon but potentially life-threatening in case of rupture. Whether these aneurysms are best treated by open repair or endovascular intervention is unknown. The aim of this retrospective study is to report the results of open and endovascular repairs in two European institutions over a fifteenyear period. We have reviewed the available literature published over the 10 last years. Methods: All patients with SRAAs diagnosed from 1995 to 2010 in St Marys Hospital (London, UK) and Henri Mondor Hospital (Créteil, France) were reviewed. Preoperative clinical and anatomical data, operative management and outcomes were recorded from the charts and analyzed. Results: 40 patients with 51 SRAAs were identified. There were 21 males and 19 females with a mean age of 57 AE 14.9 years. The aneurysms locations were: 14 (27%) renal, 11 (22%) splenic, 7 (14%) celiac trunk, 7 (14%) superior mesenteric artery, 4 (8%) hepatic, 4 (8%) pancreaticoduodenal arcades, 3 (6%) left gastric and 1 (2%) gastroduodenal. 4 patients presented with a ruptured SRAA. 17 SRAAs in 16 patients were treated by open repair, 15 in 15 patients were treated endoluminally and 17 (mean diameter: 18 mm, range: 8e75 mm) were managed conservatively. One patient with metastatic pulmonary cancer with two mycotic aneurysms of the superior mesenteric artery (75 mm) and celiac trunk (15 mm) was palliated. After endovascular treatment, the immediate technical success rate was 100%.
occurred in patients treated electively. Postoperatively, four patients (1 ruptured and 3 elective) suffered non-lethal mild to severe complication in the open repair group, as compared with one in the endovascular group (p Z .34). The mean length of stay was significantly higher after open repair as compared with endovascular repair (17 days, range: 8e56 days vs. 4 days, range: 2e6; p < .001).
The mean follow-up time was 17.8 months (range: 0e143 months) after open repair, 15.8 months (range: 0e121 months) after endovascular treatment, and 24.8 (range: 3e64 months) for patient being managed conservatively. No late death related to the VAA occurred. In each group, 2 successful reoperations were deemed necessary. In the endovascular group, two patients presented a reperfusion of the aneurysmal sac at 6 and 24 months respectively. Conclusion: No significant difference in term of 30-day mortality and post-operative complication rates could be identified between open repair and endovascular treatment in the present series. Endovascular treatment is a safe alternative to open repair but patients are exposed to the risk of aneurysmal reperfusion. This mandates careful long-term imaging follow up in patients treated endoluminally. ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Introduction
Splanchnic and renal artery aneurysms (SRAAs) are rare but increasingly diagnosed entities with current use of abdominal ultrasonography and computer tomographic (CT) imaging modalities. 1 The most commonly involved arteries are renal, splenic, and hepatic arteries. 1e5 They represent a serious and potentially lethal condition when rupture occurs. This paper, describes a combined series from two major European vascular departments, presents the outcomes of surgical and minimally invasive intervention, and examines the impact of endovascular techniques on the management of this condition. We also report an overview of the literature on SRAAs published during the last ten years.
Methods
A retrospective review of all patients with the diagnosis of SRAA at St Marys Hospital (London, UK) and Henri Mondor hospital (Créteil, France) from January 1995 to May 2010 was undertaken. Anastomotic pseudoaneurysms and aortic aneurysms involving the visceral arteries were excluded from this series. The records for all patients were analyzed with regards to demographic and clinical data, imaging studies, intraoperative data, and early and late outcomes.
The decision to perform an open repair, an endovascular intervention or conservative management was made after discussion in a multidisciplinary meeting. All ruptured and infected SRAAs underwent intervention. Infected aneurysms were defined by the presence of sepsis (fever, leukocytosis, and pain), positive cultures (blood/tissue) or characteristic radiological findings (irregular aortic wall, rapid growth rate and saccular or lobulated aneurysm). Negative blood cultures and absence of pyrexia were not used as exclusion criteria.
Open repair consisted of aneurysmorrhaphy with or without vascular reconstruction by means of direct end-toend anastomosis using vein or prosthetic graft interposition. When hilar splenic aneurysms were treated surgically, aneurysm resection and splenectomy was performed. Endovascular treatment consisted either of coil embolization, covered stent placement or combined procedures utilizing stenting/ and or coil embolization and/or Onyx injection (ev3, Irvine, CA, USA). Decisions regarding the use of stents coils or Onyx material were made intra-operatively on a patient-specific basis, depending on the anatomical characteristics of the aneurysm and specific angiographic findings. Covered stents were used in cases with adequate sealing zones, whereas coils were preferred in the presence of collaterals. Onyx material was used in cases of persistent sac perfusion or for voluminous aneurysms. Immediate technical success of endovascular repair was defined as the absence of flow in the VRAA on completion angiography.
Following open surgical correction, patients underwent duplex scanning prior to discharge, at 3, 6 months and yearly thereafter. CT scanning was performed if ultrasonography was inconclusive or an abnormality was seen such as aneurysm reperfusion or anastomotic stenosis/occlusion. Following endovascular repair, follow-up consisted of CT imaging 1e3 months post-procedure and CT/duplex scanning every one to two years thereafter. Patients treated conservatively underwent CT scanning every 6e24 months. For the purpose of this study, clinical and anatomical data, early and mid-term outcomes were compared between the open repair group and endovascular group. Patients were considered as lost to follow-up if they lacked at least one follow-up imaging study, or failed to appear in a follow-up clinic.
Statistical analysis
Proportions and categorical variables were compared using a Fisher's exact test. Continuous data were compared using a ManneWhitney. All tests were two-sided. P < .05 was considered as statistically significant.
Literature search
Series of renal and visceral artery aneurysms published in English between 2000 and 2010 were identified on Medline. Mesh headings included: "visceral artery aneurysm", "splanchnic artery aneurysm", and "renal artery aneurysm". References cited in publications identified by Medline research were examined in order to identify any missing study. Splanchnic artery aneurysms were defined as those involving the celiac trunk (splenic and hepatic arteries, pancreaticoduodenal arcade, gastroduodenal artery, and left gastric artery), superior and inferior mesenteric arteries and branches. Publications on anastomotic pseudoaneurysms after hepatic transplantation were excluded. Only more than 10 patients series were included.
Results
Forty patients with 51 SRAAs were identified (St Marys Hospital: 22 patients, 32 SRAAs; Henri Mondor Hospital: 18 patients, 19 VRAAs; see Fig. 1 ), 21 men and 19 women with a mean age of 57 AE 14.9 years. In all, there were 14 (27%) renal artery aneurysms, 11 (22%) splenic artery aneurysms, 7 (14%) celiac trunk aneurysms, 7 (14%) aneurysms of the superior mesenteric artery, 4 (8%) hepatic artery aneurysms, 4 (8%) aneurysms of the pancreaticoduodenal arcades, 3 (5%) left gastric artery aneurysms and 1 (2%) gastroduodenal artery aneurysm. The mean diameter was 21 AE 13 mm (range: 8e75). Four patients presented with a ruptured SRAA, of which two were infected. Three other non-ruptured SRAAs in two patients were considered to be infected predicated on characteristic CT appearance on CT and clinical presentation. Five patients presented with a non-ruptured but tender SRAA. The clinical and demographic data are summarized in Tables 2 and 3 . Procedure details are given in Table 3 .
Seventeen SRAAs in 13 patients with a diameter <20 mm were managed conservatively. One patient with metastatic pulmonary cancer with two infected aneurysms of the superior mesenteric artery (75 mm) and celiac trunk (15 mm), was managed conservatively due to short life expectancy; he succumbed two months later of his pulmonary disease.
There was no significant difference between the open repair and endovascular groups with respect to 30-day postoperative mortality and peri-operative complications. No inhospital death occurred in patients treated electively. One female patient died after emergent endovascular repair of a ruptured infected splenic aneurysm, who had undergone aortic valve replacement one week prior for a severe endocarditis and an aortic root abscess. Despite a successful endovascular aneurysm exclusion with coil embolization and Onyx placement, she subsequently died of septic shock.
Postoperatively, four patients (1 ruptured and 3 elective) suffered complications in the open repair group, compared with one in the endovascular group (p Z .34). In the open repair group, one patient with a ruptured infected aneurysm of the superior mesenteric artery treated by resection and saphenous vein interposition, developed pneumonia requiring prolonged intubation. One patient (non-rupture) subsequently developed a subcapsular hepatic hematoma treated with endovascular embolization and went on to develop pneumonia. Two cases of elective splenic artery ligation and splenectomy were complicated In each group, 2 reoperations were necessary. In the open repair group, one patient with a celiac trunk aneurysm treated with resection and thoracic aortic to common hepatic saphenous vein bypass was successfully reoperated on day 1 to shorten the vein bypass which appeared kinked on post-operative CT scan. The second patient presenting with a non-ruptured hepatic artery aneurysm was re-operated on day 1 for a tight stenosis of the proximal anastomosis of an aorto-hepatic prosthetic bypass. In the endovascular group two patients presenting with a renal artery and a splenic artery aneurysm required further intervention for reperfusion of the aneurysmal sac at 6 months and 2 years respectively. The patient with the renal artery aneurysm underwent an uncomplicated open ligation of the ipsilateral renal artery, without revascularization or nephrectomy due to poor renal perfusion on preoperative imaging, and the patient with the splenic artery aneurysm had a successful iterative endovascular treatment using an uncovered stent, coils and Onyx (see Fig. 3 ).
The mean follow-up time was 24.8 (range: 3e64 months) for patients managed conservatively. No patient ruptured during the follow-up period.
Discussion
The present study showed no significant difference between open and endovascular repair of SRAAs in terms of early post-operative mortality, complication and reoperation rates. The question of whether SRAAs should be treated by open or endovascular repair has never been addressed by a controlled randomized study, and only few retrospective series have been published. 5, 6 Their findings were consistent with the results reported in the present series.
In order to better evaluate the results of open repair and endovascular repair of SRAAs, we reviewed the literature. In all, we identified 1299 patients with 1528 aneurysms from 29 different publications 2e29 from the last ten years, including the present study. Among those series, eight included patients with pseudoaneurysms. There were 147 (11%) patients with ruptured aneurysms and 217 (17%) patients with symptomatic non-ruptured SRAAs. The commonest sites Figure 2 Treatment by open repair and endovascular repair by date of operation. a Two patients had a mycotic ruptured VAA (one treated by open, one endovascular repair). One patient with two mycotic aneurysms of the superior mesenteric artery and celiac trunk, and a metastatic pulmonary cancer was managed conservatively with intravenous antibiotics.
were the renal (35%), splenic (11%), hepatic (6%) and superior mesenteric (5%) arteries. 2e5 The mean age varied from 46 to 66 years. Aetiologies included atherosclerosis (51.3%), posttraumatic (12%), fibromuscular dysplasia (11%), infective (7%), post-pancreatitis (7%) and inflammatory arteritis (4%). for splanchnic aneurysms whereas fibromuscular dysplasia (68%), atherosclerosis (24%), and dissections (3%) for renal artery aneurysms.
Surgical treatment of SRAAs is clearly indicated in cases of rupture, symptoms and infective pathogenesis. 1 However, indications for surgical repair of asymptomatic lesions remain controversial. Due to a high risk of rupture during pregnancy with high mortality rates, 16, 30, 31 renal and splenic aneurysms in women of childbearing age should be treated. SRAAs associated with arteritis like polyarteritis nodosa and fibromuscular dysplasia have been linked with increased rupture rates and reports have suggested they should also be treated aggressively. 1 The relationship between renal artery aneurysms and hypertension has been emphasized and some authors believe that poorly controlled hypertension should be an indication for surgical repair. 13, 32 Currently, no consensus exists for the size at which SRAAs should be repaired in asymptomatic patients, even though those with a diameter less than 20 mm are considered to be at low risk for rupture. The natural history of SRAAs has been best illustrated by the Mayo Clinic experience: 7, 8 168 splenic (70% < 20 mm), and 22 hepatic artery aneurysms (82% < 20 mm) were managed conservatively during a mean follow-up of 74 and 68 months respectively. None of these aneurysms ruptured. We identified nine studies describing the outcome of 356 patients managed conservatively. With a mean period varying from 15 to 75 months, only one (0.3%) rupture occurred.
Analysis of the literature showed that 678 patients underwent open repair, 278 an endovascular repair and 309 were treated conservatively. The overall success rate of endovascular treatment, defined as the exclusion of the aneurysmal sac on the completion angiography, was 89.7% (262/292). Table 4 summarizes the post-operative mortality rates, according to the presence of a rupture at admission, treatment modality, and aneurysm location. Although no reliable statistical analysis can be performed from these retrospective studies, certain findings should taken into consideration. The 15.5% mortality rate seen in patients treated for ruptured SRAAs is not as high as the traditional 20e70% described in the last two decades of the twentieth century. 16,33e36 This might be explained by the increasing use of endovascular techniques and improvements in perioperative management. This review suggests that the benefits of endovascular therapy in terms of post-operative mortality is more evident for ruptured cases (2.7% endovascular vs. 23 .9% open) and not as high as expected for patients treated electively, for whom the post-operative mortality rates were low (1.2% in each group).
No study has clearly demonstrated that endovascular treatment of SRAAs is associated with a reduction of postoperative complications when compared with open repair. Specific to the endovascular treatment of splenic and hepatic aneurysms is the development of a "post -embolization syndrome", characterized by a combination of fever, abdominal pain due to splenic or hepatic infarcts, and pancreatitis seen in up to 30% of cases. 17 In our series, it occurred in one patient treated for a splenic aneurysm. Abscess formation secondary to end-organ infarct has also been reported. 5, 6 Further intervention was required for 4 patients in our series. The literature reports that further treatment was deemed necessary in 6.9% of patients treated by open repair versus 11.1% of patients treated endoluminally. In the series in which the mid-term or long-term patency rates after open procedures were reported, 89.2%e100% of vascular reconstructions remained patent after a mean follow-up of 17.8e91 months. 4, 6, 8, 9, 13, 16, 18, 20, 23 In the endovascular group, of the 241 patients assessed for SRAA reperfusion during a mean follow-up of 10e78 months, aneurysm sac reperfusion was seen in nineteen patients (7.9%). In our series, two patients presented with reperfusion at 2 years and 6 months respectively. This suggests that close imaging surveillance is necessary for patients treated by endovascular means. Long-term surveillance in a relatively younger cohort than the traditional atherosclerotic degenerative group undergoing stentgraft placement also raises questions as to both durability and repeated radiation exposure. Younger patients therefore, treated electively, may be better served with open repair where the mortality between the two modalities is very similar, whilst endovascular repair should be considered as a firstline treatment for older patients electively and all patients presenting with rupture.
Conclusion
SRAAs are rare but a serious condition. Conservative management with careful surveillance can be undertaken in those aneurysms with a diameter of less than 20 mm with the exception of women of childbearing age in whom rupture risk is high. Endovascular treatment is a valid alternative to open repair, especially for ruptured cases.
